People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Lannett Co Inc | — | Pharmaceuticals | Series B | $28.0M | $691.3M | 2021 |
David C. Drabik at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David C. Drabik on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick G. LePore | 1 | 2 |
| Timothy C. Crew | 1 | 1 |
| John C. Chapman | 1 | 1 |
| Samuel H. Israel | 1 | 1 |
| Melissa C. Rewolinski | 1 | 1 |
| John M. Abt | 1 | 1 |
| John H. Kozlowski | 1 | 1 |
| Jeffrey C. Farber | 1 | 1 |
| Maureen M. Cavanaugh | 1 | 1 |
| Robert M. Ehlinger | 1 | 1 |
| Paul C. Taveira | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.